HGH - Heartland Group Holdings

[Shareguy]

So ACC been buying 34 million shares at $1.05 average.
Most of the directors and CEO have been buying including its chair who added another 13.8 million shares, giving him control of 83m shares.

Gives me comfort holding this stock and think great buying under a $1. Time will tell and not long to wait for results.

Disc/Have been buying for family trust.

[Basil]

Almost like you read my mind mate. Been thinking today, this is one of the few stocks that have not caught the tailwind of RBNZ announcement and the lower inflation announcement today (3.3% annual), adds to prospects of an earlier interest rate cut.

Interestingly, noted on CNBC this morning the US regional bank index is up just on 50% since the October 2023 low.  Talk of great prospects ahead with average PE in that sector in the very low teens but I wryly noted HGH is on a forward PE of only about half that.

Makes me wonder how much more selling can there be under $1?  Maybe an opportunity for those to think about that don't already have a decent sized allocation.....or wait for TA support. 

[KW]

Almost like you read my mind mate. Been thinking today, this is one of the few stocks that have not caught the tailwind of RBNZ announcement and the lower inflation announcement today (3.3% annual), adds to prospects of an earlier interest rate cut.

Interestingly, noted on CNBC this morning the US regional bank index is up just on 50% since the October 2023 low.  Talk of great prospects ahead with average PE in that sector in the very low teens but I wryly noted HGH is on a forward PE of only about half that.

Makes me wonder how much more selling can there be under $1?  Maybe an opportunity for those to think about that don't already have a decent sized allocation.....or wait for TA support. 

Australian banks are also on a tear.  Which means there are good reasons for HGH to be priced the way it is.  Wait until the Aussie bank analysts put a buy rec on it, and the funds start buying in.  

[Shareguy]

Australian banks are also on a tear.  Which means there are good reasons for HGH to be priced the way it is.  Wait until the Aussie bank analysts put a buy rec on it, and the funds start buying in. 

Yes hopefully it gets more coverage. Given how small a company it is in Australia I suspect will need to get some runs on the board first. Share price has been holding up between a tight range for a while.

In NZ we are seeing banks dropping interest rates with possibly two cuts in the OCR this year, which will have a lot more funds coming into the markets. I'm picking the NZ market will have a great second half.

Can also understand being cautious and waiting for the results as there is some I think warranted concern.  However I just think there is limited downside from here and will sleep well knowing our chair has 83 million shares to make sure this company is successful.

[Shareguy]

Almost like you read my mind mate. Been thinking today, this is one of the few stocks that have not caught the tailwind of RBNZ announcement and the lower inflation announcement today (3.3% annual), adds to prospects of an earlier interest rate cut.

Interestingly, noted on CNBC this morning the US regional bank index is up just on 50% since the October 2023 low.  Talk of great prospects ahead with average PE in that sector in the very low teens but I wryly noted HGH is on a forward PE of only about half that.

Makes me wonder how much more selling can there be under $1?  Maybe an opportunity for those to think about that don't already have a decent sized allocation.....or wait for TA support. 

Yes HGH not feeling the love like the rest of the market. Gosh what a great week. Heartland already have a good business in Australia so it's not like a lot of NZ companies that have struggled in the lucky country.  I think you picked it at $.96

[Basil]

Off the top of my head I'm stoll a bit underwater on this one but as the old Mainland cheese advertisement jingle goes, good things take time.

[TGB]

Grabbed a few more today, I'm sure when I'm old I will thank myself.

[Buzz]

There is a lot resting on the Aus/International fundies recognising HGH, which none of them will do until HGH is in the appropriate market cap to be within their portfolio allocations. Same in NZ imo.

If you believe this will happen, along with the inevitable re-rate if it happens, then now is a good time to load up. It then becomes a question of HGH execution in market and the time before it is realised.

[SCOTTY]

Solid day for HGH today. 2.487m traded, VWAP 98.753cps - last trade 289,794 @ $1.00. Very light on the sell side at close

[Basil]

Makes me wonder how much more selling can there be under $1?

Posed that question only 2 days ago.  Now look, it appears we have a breakout.   Bugger...I was just thinking this morning I should get some more under $1.

[TGB]

Not even old yet and I'm thanking myself. Also wishing I had grabbed a few more but OCA wasn't a bad shout either

[raW tent Buffer]

Yes, my buy order at 97c didn't fill yesterday which is a bit disappointing... Any idea what has prompted this morning's surge?

[TGB]

Cpi data and banks starting to lower those interest rates. Patience being rewarded here.

[LoungeLizard]

I'm bound to say that we've seen these false dawns and blips in HGH many times, some very recently. This may be the start of the recovery but we won't know whether it is real or speculative until the end of year results.

[Basil]

I'm bound to say that we've seen these false dawns and blips in HGH many times, some very recently. This may be the start of the recovery but we won't know whether it is real or speculative until the end of year results.

While that's fair comment, it's also fair to say many parts of the market, especially interest rate sensitive stocks, have appreciated markedly in recent days on nothing more than a wing and a prayer of hope that green shoots might start emerging this spring.  It seems quite evident we're at, or very, very close to the bottom of this economic cycle and also food for thought on your other comment about end of year financial results, HGH is by no means the only company with potentially has some skeletons that might be lurking in the closet.  Plenty of risk evident elsewhere in the market including in some stocks that have made a complete and utter hash of things in recent years and yet have appreciated nearly 20% in recent days (I'm looking at you RYM as a classic case in point).